Next Article in Journal
Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in Hormonal Contraceptive Users. Comment on “Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. Pharmaceuticals 2025, 18, 61”
Previous Article in Journal
RETRACTED: Naamneh et al. Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals 2024, 17, 549
 
 
Comment

Article Versions Notes

Pharmaceuticals 2025, 18(9), 1401; https://doi.org/10.3390/ph18091401
Action Date Notes Link
article html file updated 18 September 2025 11:13 CEST Original file https://www.mdpi.com/1424-8247/18/9/1401/html
article pdf uploaded. 18 September 2025 11:10 CEST Version of Record https://www.mdpi.com/1424-8247/18/9/1401/pdf
article xml uploaded. 18 September 2025 11:10 CEST Update https://www.mdpi.com/1424-8247/18/9/1401/xml
article xml file uploaded 18 September 2025 11:10 CEST Original file -
Back to TopTop